Cigna Investments’s Innoviva INVA Stock Holding History

Cigna Investments’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,903	Closed	-$152K	–	746
2018 Q3	$152K	Buy	+10,903	New	+$157K	0.01%	709

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cigna Investments's INVA Position: Q4 2018 in Review

Cigna Investments sold out of Innoviva (INVA) in Q4 2018, closing a stake of 10,903 shares — an estimated $152K sold.

Cigna Investments first reported a position in INVA in Q3 2018 and held it in 1 quarter. The position peaked at $152K in Q3 2018. 233 funds tracked by Wall St. Rank hold INVA as of Q4 2018.

Cigna Investments reported no remaining Innoviva position as of Q4 2018 after selling out during the quarter.
Cigna Investments sold 10,903 Innoviva shares in Q4 2018, an estimated $152K.
Cigna Investments first reported a position in Innoviva in Q3 2018 and held it in 1 quarter.
Cigna Investments's Innoviva position peaked at $152K in Q3 2018.
233 funds tracked by Wall St. Rank held Innoviva as of Q4 2018.

Based on Cigna Investments's 13F filing for Q4 2018, filed 6 Feb 2019.